The collection and analysis of medicines data, will enable information to be obtained about the spend and usage of medicines, by NHS providers commonly referred to as secondary care, and may include but may not be limited to:

• NHS acute providers (providing largely hospital-based services)
• NHS community providers (providing services such as district nursing, health visiting)
• NHS mental health providers
• NHS specialist providers (providing services such as specialist eyecare or cancer treatment)
• NHS ambulance services
• organisations commissioned by the NHS to provide NHS services, including medicines supply and medicines stock control services.

Under section 259 of the Health and Social Care Act 2012.

The collection period starts from the date of publication of this Data Provision Notice (DPN). Due to the discovery nature of this work, data collections will be on an ad hoc basis and will be agreed between NHS Digital and those NHS providers who have agreed to participate. This DPN will be reviewed before the end of March 2021.

April 2020: Update: Note that the work to establish a secondary care medicines data collection from pharmacy stock control has been paused. This decision has been taken in response to the national Covid-19 emergency and the consequent need for NHS Digital, and other NHS bodies including trusts and their system suppliers, to prioritise work accordingly. Stakeholders involved in this work will be contacted as and when this work is resumed.

This list will be updated as and when further providers agree to participate.